GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Change in Cash

MicroTech Medical (Hangzhou) Co (HKSE:02235) Net Change in Cash : HK$19.6 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

MicroTech Medical (Hangzhou) Co's Net Change in Cash for the six months ended in Dec. 2024 was HK$-125.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was HK$19.6 Mil.

MicroTech Medical (Hangzhou) Co Net Change in Cash Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Net Change in Cash Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial 590.79 1,972.84 -560.51 -786.22 -28.57

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only -404.40 -500.91 -152.76 145.23 -125.63

MicroTech Medical (Hangzhou) Co Net Change in Cash Calculation

MicroTech Medical (Hangzhou) Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-128.81+129.355+-35.394+6.277
=-28.6

MicroTech Medical (Hangzhou) Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=0+-88.009+-41.314+3.698
=-125.6

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$19.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroTech Medical (Hangzhou) Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Change in Cash
Comparable Companies
HKSE:09877 HKSE:06669 HKSE:02160 HKSE:01696 HKSE:09996 HKSE:01763 HKSE:02216 HKSE:02500 HKSE:06922 HKSE:06609 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.microtechmd.com
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Orbimed Asia Partners V, L.p. 2101 Beneficial owner
Orbimed Asia Gp V, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors V Limited 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Ii, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Gp, L.p. 2201 Interest of corporation controlled by you
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Zheng Pan
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you

MicroTech Medical (Hangzhou) Co Headlines

No Headlines